in 
, via 
| she/her
Like many other outlets, we've been using and featuring research that hasn't been peer reviewed. We try to do due diligence by checking methods, code and data, but it's hard to do, especially this quickly.
Show this thread
Fantastic article by @jackiefmogensen about the difficulties with doing -- and reporting on -- science too quickly, especially when it's getting so much attention. This is something we struggle with at @FiveThirtyEight, as well.https://www.motherjones.com/politics/2020/04/coronavirus-science-rush-to-publish-retractions/ …
-
-
-
Some of the research being produced right now has flaws. But science is always iterative, and doing it at super high speed is *hard*. One paper should never be treated as definitive, but especially now, the media has a real responsibility to vet research it features.
Show this thread
End of conversation
New conversation -
-
-
When the media reports a potential treatment, people rush out to try it and there’s a shortage. Then, people who really, non-speculatively need it can’t get it. This happened to hydroxychloroquine (which I take for lupus) and is starting to happen with other drugs now.
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.